An immunoassay analyzer for clinics helps healthcare professionals measure specific biomarkers to support the assessment of infections, inflammation, cardiovascular conditions, hormonal disorders, and other health concerns. Bringing these tests closer to the point of care can reduce dependence on external laboratories and help clinicians access relevant results during patient visits.

However, not every clinic needs the same testing capabilities. The right analyzer depends on its clinical applications, test menu, sample requirements, processing capacity, and compatibility with daily workflows.

What Is an Immunoassay Analyzer?

An immunoassay analyzer is a diagnostic instrument that detects or measures specific substances in a patient sample through antigen-antibody reactions. These substances, known as analytes, may include proteins, hormones, antibodies, and other biomarkers.

Immunoassay testing is widely used in clinical settings because it can support the assessment of multiple conditions using relatively small sample volumes.

How Immunoassay Testing Works

Most immunoassays rely on the specific binding between an antibody and its corresponding antigen.

A typical testing process involves:

1. Sample collection: A blood, serum, or plasma sample is collected according to the test requirements.
2. Target recognition: Reagents interact with the target analyte in the sample.
3. Signal generation: A detectable signal is produced through a chemical, fluorescent, or other labeling method.
4. Signal measurement: The analyzer measures the signal and processes it to generate a test result.

The exact procedure depends on the assay technology and analyzer design. Automated systems help standardize these steps and reduce manual handling.

Common Immunoassay Technologies

Different immunoassay technologies are used in clinical diagnostics. Common approaches include:

• Fluorescence immunoassay (FIA): Uses fluorescent signals to detect or quantify target substances.
• Chemiluminescence immunoassay (CLIA): Measures light generated through a chemical reaction.
• Enzyme-linked immunosorbent assay (ELISA): Uses enzyme-labeled reactions to produce a measurable signal.
• Lateral flow immunoassay: Uses capillary action to move a sample through a test strip and generate a detectable result.

Clinics should select a system based on the required biomarkers, testing volume, workflow, and available consumables rather than technology names alone.

Common Immunoassay Tests in Clinics

Immunoassay testing supports several areas of routine and specialized clinical assessment. The available test menu varies by analyzer, reagent configuration, and local clinical requirements.

Inflammation and Infection Markers

Inflammatory biomarkers help clinicians assess inflammatory responses and support the evaluation of suspected infections.

Common tests include:

• C-reactive protein (CRP): Helps assess systemic inflammation.
• Procalcitonin (PCT): Can support the evaluation of bacterial infections and sepsis risk.
• Interleukin-6 (IL-6): A cytokine associated with inflammatory and immune responses.
• Serum amyloid A (SAA): An acute-phase protein that can increase during inflammation.

These markers should be interpreted alongside symptoms, medical history, and other laboratory findings. No single biomarker can independently establish a diagnosis.

Cardiac Biomarkers

Cardiac immunoassays help assess biomarkers associated with heart muscle injury and cardiovascular conditions.

Frequently used tests include:

• Cardiac troponin I (cTnI): Supports the assessment of myocardial injury.
• NT-proBNP: Helps evaluate cardiac strain and support heart failure assessment.
• CK-MB: A cardiac-associated enzyme marker that may be used in selected clinical contexts.

Timely access to these results can support clinical assessment, particularly in facilities that handle patients with suspected cardiovascular conditions.

Thyroid and Hormone Tests

Hormone-related immunoassays are used to evaluate endocrine function and investigate symptoms associated with hormonal imbalances.

Common tests include:

• T3 and T4: Thyroid hormones involved in regulating metabolism.
• TSH: A hormone used to assess thyroid function.
• FT3 and FT4: Free thyroid hormone measurements.
• LH and FSH: Hormones involved in reproductive function.
• Progesterone and estradiol: Hormones relevant to reproductive and endocrine assessment.

The specific tests required depend on the patient’s symptoms and the clinician’s diagnostic plan.

Diabetes-Related Markers

Immunoassay-based testing can also support diabetes assessment and metabolic monitoring.

One important marker is HbA1c, which reflects average blood glucose levels over approximately the previous two to three months. It is commonly used in diabetes screening and long-term glucose management.

Some analyzers also integrate immunoassay testing with separate biochemical tests, allowing clinics to cover a broader range of metabolic assessments.

Why Clinics Need an Immunoassay Analyzer

For clinics that regularly request biomarker testing, an in-house analyzer can improve access to diagnostic information and simplify parts of the testing process.

Faster Results for Clinical Decisions

Sending samples to an external laboratory may involve transportation, processing queues, and additional reporting time. An in-house analyzer can shorten this process for supported tests.

With results available closer to the patient visit, clinicians may be able to:

• Review relevant biomarkers during the consultation.
• Make more timely decisions about further examinations.
• Reduce delays associated with sample transportation.
• Plan follow-up care with more accessible test information.

Actual turnaround time depends on the assay, analyzer, sample preparation, and workload.

Convenient Testing with Small Sample Volumes

Some compact immunoassay systems support testing with relatively small sample volumes. This can be useful in outpatient settings where convenient sample collection is important.

Before purchasing an analyzer, clinics should check:

• Whether it supports venous or capillary samples.
• The required sample volume for each assay.
• Whether serum or plasma preparation is necessary.
• Whether different tests require different collection procedures.

A small sample requirement can simplify collection, but it should not replace consideration of assay performance and sample compatibility.

Improved Access to Point-of-Care Testing

Point-of-care testing allows selected diagnostic tests to be performed near the patient rather than exclusively in a central laboratory.

For clinics, this approach may help reduce dependence on external testing services for frequently requested biomarkers. It can also support decentralized healthcare settings where access to a full laboratory is limited.

However, point-of-care testing still requires appropriate quality control, operator training, and result interpretation to maintain reliable clinical practice.

Key Factors to Consider When Choosing an Immunoassay Analyzer for Clinics

Choosing an analyzer requires more than comparing its advertised test menu. Clinics should evaluate how well the system matches their actual diagnostic needs and operating conditions.

Test Menu and Clinical Applications

Start by identifying the biomarkers your clinic needs most frequently.

For example:

• Primary care clinics may prioritize inflammation, infection, and diabetes-related markers.
• Cardiology-focused facilities may need cardiac biomarkers.
• Endocrine clinics may require thyroid and reproductive hormone testing.
• Emergency care settings may prioritize tests that support time-sensitive clinical assessments.

Check whether the analyzer supports the required assays and whether the corresponding reagents are available in your market.

Testing Speed and Throughput

Testing speed affects how efficiently a clinic can handle its daily workload.

Consider both the time required to complete an individual test and the total number of samples the analyzer can process within a given period.

A clinic with occasional testing needs may not require a high-throughput system. Facilities with larger patient volumes should pay closer attention to processing capacity, test scheduling, and the possibility of multiple tests being performed in one workflow.

Sample Types and Sample Requirements

Sample compatibility directly affects how an analyzer fits into routine clinical operations.

Review the manufacturer’s specifications for:

• Supported sample types, such as whole blood, serum, and plasma.
• Required sample volume.
• Sample preparation procedures.
• Collection tube and anticoagulant requirements.
• Storage and handling conditions.

Confirm these details for each intended assay because requirements may differ across test items.

Operation and Maintenance

An analyzer should be practical for the staff who will use it every day.

Important considerations include:

• User interface and testing procedures.
• Reagent preparation and storage.
• Calibration and quality control requirements.
• Cleaning and routine maintenance.
• Technical support and operator training.

A system with simplified consumable handling and clear operating procedures may reduce the operational burden on clinics with limited laboratory personnel.

Equipment Cost and Long-Term Value

The initial purchase price is only one part of the total investment.

Clinics should also estimate recurring expenses, including reagents, consumables, calibration materials, maintenance, and technical support.

It is useful to compare the cost per test based on expected testing volume. A lower-priced analyzer may not provide the best long-term value if its consumables are expensive or its test menu does not match the clinic’s needs.

Immunoassay Analyzer or Multi-Functional Analyzer for Clinics?

A standalone immunoassay analyzer focuses on biomarker testing, while a multi-functional analyzer combines immunoassay with other diagnostic capabilities. The better option depends on the range of tests a clinic performs and how its diagnostic workflow is organized.

A dedicated immunoassay analyzer may be suitable when:

• Immunoassay testing accounts for most of the clinic’s in-house diagnostic workload.
• The clinic needs a specialized test menu or higher capacity for specific assays.
• Hematology and biochemistry testing are already handled by separate instruments.

A multi-functional analyzer may be worth considering when a clinic wants to consolidate several types of blood testing into one system. This can help make better use of limited workspace and simplify equipment management.

Integrated Testing with the Ozelle EHBT-50

At Ozelle, we offer the Многофункциональный лабораторный анализатор EHBT-50 Mini Lab, which integrates hematology, immunoassay, and biochemistry testing in one system.

Its immunoassay module uses fluorescence immunochromatographic analysis. The supported test menu covers several clinical areas, including:

• Inflammation: CRP, CRP/SAA, IL-6, and PCT.
• Cardiac assessment: cTnI, NT-proBNP, and CK-MB.
• Diabetes and metabolic assessment: HbA1c.
• Thyroid function: T3, T4, and TSH.
• Additional testing: D-dimer and other available assays, depending on configuration and market availability.

Beyond immunoassay, the EHBT-50 combines 7-differential hematology analysis with dry biochemical testing. Its integrated design allows clinics to perform different categories of blood tests on one platform instead of relying entirely on separate instruments.

The system supports whole blood, capillary blood, serum, and plasma. It also features a built-in diagnostic workbench that brings test orders and result review into one workflow.

For clinics considering a broader in-house testing setup, our human diagnostic analyzer portfolio provides an overview of the available systems and their different testing capabilities.

How to Integrate Immunoassay Testing into Daily Clinic Workflows

Installing an analyzer is only one part of establishing reliable in-house testing. Clinics also need clear procedures for sample handling, testing, result review, and quality control.

Sample Collection and Preparation

Follow the sample requirements specified for each assay. Incorrect collection, unsuitable sample types, or improper handling may affect test performance.

A practical workflow should define:

• Which sample types are accepted for each test.
• How samples are collected, labeled, and stored.
• Whether centrifugation or other preparation is required.
• How samples are handled before testing.

Staff should receive training on these procedures before routine testing begins.

Testing and Result Interpretation

Operators should follow the analyzer’s instructions for loading samples, selecting tests, and handling consumables.

After testing, results should be reviewed in the context of the patient’s symptoms, medical history, and other relevant findings. Unexpected or inconsistent results may require repeat testing or confirmation through an appropriate laboratory method.

Clinics should also establish procedures for documenting results and communicating clinically important findings to the responsible healthcare professional.

Quality Control and Routine Maintenance

Consistent quality control helps clinics monitor analyzer performance and identify potential problems.

A routine quality management process should cover:

• Running quality control materials according to the manufacturer’s instructions.
• Reviewing calibration and quality control records.
• Monitoring reagent storage conditions and expiration dates.
• Following recommended cleaning and maintenance procedures.
• Recording errors, corrective actions, and service activities.

The exact frequency and procedures depend on the analyzer, assay, manufacturer instructions, and applicable local regulations.

Making the Right Immunoassay Testing Investment for Your Clinic

The right immunoassay analyzer should match a clinic’s clinical priorities, daily testing volume, staffing resources, and budget. Before making a decision, evaluate the available test menu, sample requirements, analytical performance, operating costs, and quality control procedures.

Clinics that mainly perform specialized biomarker testing may benefit from a dedicated immunoassay system. Those that need broader diagnostic coverage may find an integrated platform more practical.

At Ozelle, we develop diagnostic systems for healthcare facilities with different testing requirements. If you are evaluating an immunoassay solution or considering a multi-functional analyzer, свяжитесь с нашей командой to discuss your clinical applications, expected workload, and equipment requirements.